Was this not posted - OTC Markets Group Welcomes New OTCQB Companies – August 8
Announcement | 08/08/2022
OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, announced the following companies are approved for trading on the OTCQB Venture Market:
Active Energy Group Plc (LSE: AEG; OTCQB: ATGVF) Active Energy Group plc is a London listed (AIM: AEG) renewable energy company focused on the production and development of next generation biomass products that have the potential to transform traditional coal fired power and heavy industries and the existing renewable biomass industry. AEG has developed a proprietary technology platform which transforms waste biomass material into high-value renewable fuels. Its patented product CoalSwitch is a leading drop-in biomass renewable fuel that can be co-fired with coal, completely replace coal as an alternative feedstock without requiring significant plant modifications or wholly replace existing biomass feedstock resources . Active Energy Group's immediate strategic focus is the production and commercialization of CoalSwitch. CoalSwitch is a registered trademark belonging to Active Energy Group plc.
Kesselrun Resources Ltd. (TSX-V: KES; OTCQB: KSSRF) Kesselrun Resources Ltd. is a Thunder Bay, Ontario-based mineral exploration company focused on growth through property acquisitions and discoveries. Kesselrun's management team possesses strong geological and exploration experience with particular expertise in Northwest Ontario.
NovAccess Global Inc. (OTCQB: XSNX) NovAccess Global Inc. is a biopharmaceutical company focused on the development and commercialization of novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. NovAccess Global are experts in cutting-edge research involving the use of a patient's own immune system to fight cancer. Through their advisory board they have experience successfully executing clinical trials, bringing products to market and increasing the market size of products.
Sigyn Therapeutics Inc. (OTCQB: SIGY) Sigyn Therapeutics, Inc, is a development-stage therapeutic technology company headquartered in San Diego, California USA. Their focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Sigyn Therapeutics mission is to save lives. Sigyn Therapy is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the most common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a leading cause of SARS-CoV-2 (COVID-19) deaths. Other therapeutic opportunities include, but are not limited to bacteria induced cytokine storm (BICS), acute respiratory distress syndrome (ARDS) and acute forms of liver failure, such as hepatic encephalopathy.
The INX Digital Company, Inc. (NEO: INXD; OTCQB: INXDF) The INX Digital Company, Inc. is the holding company for the INX Group, which includes regulated trading platforms for digital securities and cryptocurrencies, combining traditional markets expertise and an innovative fintech approach. The INX Group's vision is to be the preferred global regulated hub for digital assets on the blockchain. The INX Group's overall mission is to bring communities together and empower them with financial innovation.
The Planting Hope Company Inc. (TSX-V: MYLK; OTCQB: MYLKF) The Planting Hope Company Inc. develops, launches and scales uniquely innovative plant-based and planet-friendly food & beverage brands. Their groundbreaking products fill key unmet needs in the rapidly-growing plant-based food & beverage space. Founded by experienced food industry entrepreneurs, The Planting Hope Company Inc. is a women-managed and led company focused on three impact pillars: nutrition, sustainability, and representation.
VVC Exploration Corporation (TSX-V: VVC; OTCQB: VVCVF) VVC engages in the exploration, development, and management of natural resources - specializing in scarce and increasingly valuable materials needed to meet the growing, high-tech demands of industries such as manufacturing, technology, medicine, space travel, and the expanding green economy. VVCs portfolio includes a diverse set of multi-asset, high-growth projects, comprising: Helium & industrial gas production in western U.S.; Copper & associated metals operations in northern Mexico; and Strategic investments in carbon sequestration and other green energy technologies. By taking a uniquely opportunistic approach, while limiting development risks, VVC aims to deliver superior results to shareholders by leveraging substantial industry expertise to build a diversified, growth-driven portfolio.
XCELERATE INC. (OTCQB: XCRT) Xcelerate has assembled an internationally recognized team of translational clinicians, engineers and business leaders to identify, acquire, and develop engineering advancements, intellectual property and operating business in, or with applications in medical technology and clinical care. Xcelerate acquires innovation at the engineering / patent level, marries it with appropriate early-stage operational med tech companies and applies it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella.
